sur Vitruvia Medical AG (isin : CH0461931419)
Vitruvia Medical AG Reports Promising Half-Year Results for 2026
Vitruvia Medical AG has released its half-year results for 2026, aligning with expectations and confirming a positive business trajectory. The company reported a significant earnings improvement, reaching CHF 125,785.97, compared to a loss of CHF 72,889.88 in the same period the previous year. This substantial increase underscores the company's growth path.
The management has reaffirmed its optimistic outlook for the full year, relying on steady business performance and favorable trends observed in the first half of 2026. LT technologies GmbH & Co. KG, Vitruvia's wholly owned subsidiary, recorded strong performance, achieving its half-year revenue target of €1.3 million, setting the stage to meet the annual target of €2.6 million.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Vitruvia Medical AG